Fact-checked by Grok 2 weeks ago

Decompressive craniectomy

Decompressive craniectomy is a neurosurgical in which a large portion of the is surgically removed to allow the swollen to expand beyond the rigid , thereby reducing life-threatening caused by conditions such as or . This intervention is typically considered a last-resort measure after medical treatments like , osmotherapy, and fail to control refractory intracranial , which can lead to and death if untreated. The involves opening the underlying to maximize and may be performed unilaterally (hemicraniectomy) or bilaterally (bifrontal craniectomy), depending on the location and extent of swelling. The primary indications for decompressive craniectomy include severe traumatic brain injury with elevated intracranial pressure, malignant middle cerebral artery infarction, acute subdural hematoma, and sometimes subarachnoid or intracerebral hemorrhage when conservative management is insufficient. During the surgery, the removed bone flap is typically stored in a freezer or abdominal subcutaneous pocket for future cranioplasty, which reconstructs the skull several months later to protect the brain and restore normal physiology. Timing is critical, with guidelines recommending intervention within hours of refractory pressure elevation to optimize outcomes, though early prophylactic use has shown limited benefits in randomized trials. Historically, decompressive craniectomy traces its roots to ancient trephination practices over 10,000 years ago, but its modern form was refined in the early by surgeons like Theodor Kocher and Harvey Cushing for wartime . While it significantly lowers mortality rates—for instance, from 48.9% to 26.9% at six months in patients with according to the RESCUEicp trial—survivors often face higher risks of severe disability, vegetative states, or dependency compared to medical management alone. Complications can include , , syndrome of the trephined, and challenges during , underscoring the need for careful patient selection based on age, comorbidities, and injury severity. Current guidelines from organizations like the Brain Trauma Foundation endorse its use to improve mortality and favorable outcomes in patients with severe and refractory intracranial hypertension in select cases, while weighing long-term quality-of-life implications.

Overview

Definition

Decompressive craniectomy is a neurosurgical intervention that involves the surgical removal of a large portion of the , referred to as the flap, typically measuring at least 12 × 15 cm in size, without immediate replacement. This procedure is combined with a wide incision of the underlying to enable the expansion of tissue beyond the confines of the , thereby reducing compressive forces on the . The primary goal of decompressive craniectomy is to create additional for edematous or swollen tissue, preventing potentially fatal herniation and ischemia caused by unchecked intracranial . Two principal variants exist: unilateral hemicraniectomy, which targets focal lesions on one side of the , and bifrontal craniectomy, which addresses diffuse bilateral swelling across the frontal regions. This procedure is distinct from a , where the bone flap is temporarily removed but replaced immediately to restore integrity, and from trephination (or burr hole drainage), which creates only a small opening in the for localized or evacuation rather than broad .

Physiological rationale

Decompressive craniectomy addresses intracranial hypertension arising from , a where swelling elevates (), thereby compromising (). is calculated as the difference between () and , using the formula \text{CPP} = \text{MAP} - \text{ICP}. When rises unchecked, falls below critical thresholds (typically <60 mm Hg), leading to cerebral ischemia and potentially fatal herniation syndromes. This pathophysiology aligns with the Monro-Kellie doctrine, which posits that the intracranial compartment is a fixed-volume space containing brain tissue, blood, and cerebrospinal fluid (CSF), with their combined volumes remaining constant under normal conditions. Compensatory mechanisms, such as displacement of CSF or venous blood, initially mitigate volume increases from edema, but once exhausted, ICP escalates exponentially, further impairing cerebral blood flow and autoregulation. By removing a portion of the skull and dura, decompressive craniectomy creates an expandable space, permitting edematous brain tissue to herniate outward through the bony defect. This intervention normalizes ICP and enhances intracranial compliance, shifting the pressure-volume curve (where compliance is defined as C = \frac{dV}{dP}, the change in volume per unit change in pressure) to allow greater volume accommodation without proportional ICP rises. Supporting evidence from animal models, such as rat studies of malignant hemispheric infarction, demonstrates that early decompression restores cerebral blood flow by alleviating compressive forces on vasculature. Similarly, early human investigations, including those from the late 20th century, report increased cerebral blood flow velocities post-procedure in traumatic brain injury patients, correlating with improved perfusion dynamics.

Indications

Traumatic brain injury

Decompressive craniectomy serves as a primary surgical intervention for severe (TBI), particularly in cases of refractory intracranial hypertension where intracranial pressure (ICP) persists above 20-25 mmHg despite aggressive medical management. Maximal medical therapy typically encompasses tiered approaches such as osmotherapy using mannitol or hypertonic saline to draw fluid from brain tissue, controlled hyperventilation to induce vasoconstriction and lower cerebral blood volume, sedation, and cerebrospinal fluid drainage. This procedure is reserved for patients with diffuse brain swelling rather than localized lesions, as it physiologically permits outward herniation of swollen brain tissue to alleviate pressure, though the detailed mechanisms are outlined in the physiological rationale section. The Brain Trauma Foundation guidelines recommend decompressive craniectomy for adults with severe TBI, defined by a (GCS) score of 3-8 accompanied by abnormal computed tomography (CT) findings such as cistern compression or midline shift, when ICP elevation proves unresponsive to medical interventions. Timing of the procedure varies: early intervention within 48 hours may be considered for diffuse injuries to preempt deterioration, while late salvage craniectomy is often employed beyond this window as a rescue measure for ongoing refractory hypertension. These recommendations stem from evidence balancing the risks of cerebral ischemia against the benefits of pressure reduction in non-penetrating, diffuse TBI patterns. Patient selection emphasizes younger adults under 40 years, who demonstrate better tolerance and potential for recovery due to greater physiological reserve, particularly in the context of diffuse axonal injury characterized by widespread white matter shearing without discrete mass effects. Focal mass lesions, such as epidural or subdural hematomas, are generally contraindicated for primary decompressive craniectomy, as evacuation via craniotomy is preferred to directly address the lesion. In clinical practice, decompressive craniectomy accounts for approximately 10-15% of surgical cases among patients with severe TBI requiring operative intervention, reflecting its role as a targeted rather than routine procedure.00338-3/fulltext)

Ischemic stroke

Decompressive craniectomy is indicated for patients with malignant infarction, characterized by large hemispheric infarcts involving more than 50% of the MCA territory, accompanied by cerebral edema that leads to significant mass effect, such as midline shift greater than 5 mm or exceeding 20 mmHg. These infarcts typically manifest 2 to 4 days after stroke onset, resulting in life-threatening brain herniation if untreated. The procedure aims to alleviate intracranial hypertension by removing a large portion of the skull, allowing the swollen brain tissue to expand without further compression. Randomized controlled trials, including DECIMAL, DESTINY, and HAMLET, have provided robust evidence supporting decompressive craniectomy in this context. A pooled analysis of these trials demonstrated that early surgical intervention significantly reduces mortality, from 78% in medically managed patients to 29% in those undergoing craniectomy, particularly among individuals under 60 years of age.61172-1/fulltext) This analysis, involving 93 patients, also showed an increase in favorable functional outcomes, with more survivors achieving modified Rankin Scale scores of 0 to 3 at 12 months.61172-1/fulltext) The trials collectively enrolled patients with severe neurological deficits and radiological evidence of extensive infarction, confirming the procedure's role in preventing fatal outcomes from edema-related complications.61046-1/fulltext) Patient selection for decompressive craniectomy emphasizes age under 55 to 60 years, as older individuals may experience less benefit due to comorbidities and reduced neuroplasticity. Considerations for hemisphere involvement include potential language or sensory deficits in dominant hemisphere strokes, which historically raised concerns about quality of life; however, meta-analyses indicate comparable functional outcomes between dominant and non-dominant infarcts, supporting surgery in both cases when other criteria are met. Optimal timing is within 48 hours of symptom onset, as earlier intervention correlates with lower mortality and better survival with independence, based on trial data showing superior results compared to delayed procedures.61172-1/fulltext)

Other conditions

Decompressive craniectomy has been employed in cases of malignant cerebral edema arising from primary brain tumors such as , where rapid swelling leads to refractory intracranial hypertension despite medical management. In pediatric patients with , emergency hemicraniectomy has been performed to evacuate mass effect and alleviate pressure, allowing for subsequent tumor-directed therapies. Similar applications extend to infectious etiologies causing severe edema, including cerebral abscesses and malaria. For brain abscesses, decompressive craniectomy serves as an adjunct when abscess-related swelling causes life-threatening herniation, particularly in cases with extensive surrounding edema exceeding 2.5 cm in diameter. In cerebral malaria, particularly Plasmodium falciparum infections, decompressive procedures have been used to manage intracranial hypertension from diffuse edema and associated hematomas, though outcomes remain guarded due to the underlying systemic infection. Additionally, decompressive craniectomy addresses malignant edema in hypoxic-ischemic encephalopathy, often following global insults like near-drowning or asphyxia, by providing space for brain expansion in diffuse injury patterns. Decompressive craniectomy is also used in select cases of intracerebral or subarachnoid hemorrhage with malignant edema and refractory intracranial hypertension unresponsive to evacuation and medical therapy. Rare indications include fulminant hepatic failure with cerebral edema, where bilateral decompressive craniectomy has been reported to control intracranial hypertension in acute liver dysfunction, potentially bridging patients to transplantation. In refractory status epilepticus, decompressive craniectomy mitigates edema-induced pressure elevation when seizures contribute to secondary brain injury, as seen in case reports of invasive monitoring-guided interventions. For idiopathic intracranial hypertension unresponsive to ventriculoperitoneal shunting, cranial vault decompression offers a salvage option by expanding the calvarial volume and reducing pressure on optic nerves and brainstem structures. Case series demonstrate efficacy in pediatric abusive head trauma, where decompressive craniectomy reduces mortality in select cohorts with severe swelling, though nonaccidental mechanisms are associated with higher overall fatality rates compared to accidental injuries. In post-cardiac arrest cerebral swelling, early decompressive craniectomy has shown potential to lower mortality by up to 50% in small cohorts by interrupting herniation and ischemia cascades, particularly when combined with targeted temperature management. Relative contraindications for decompressive craniectomy include advanced age greater than 65 years, which is associated with poorer functional recovery due to reduced brain plasticity; bilateral fixed and dilated pupils indicating advanced herniation; and irreversible brainstem damage, often evidenced by Glasgow Coma Scale scores below 4 with absent brainstem reflexes.

Surgical procedure

Preoperative assessment

Preoperative assessment for decompressive craniectomy involves a multidisciplinary evaluation to confirm indications, optimize patient condition, and ensure informed decision-making, particularly in cases of refractory intracranial hypertension from traumatic brain injury (TBI) or ischemic stroke. This process typically includes neuroimaging to quantify mass effect, invasive monitoring to verify elevated intracranial pressure (ICP), correction of reversible physiological derangements, and detailed discussions of risks with patients or surrogates. Imaging plays a central role in assessing the extent of brain swelling and herniation risk. Non-contrast computed tomography (CT) of the head is the primary modality, used to identify midline shift greater than 5 mm, effaced basal cisterns, or significant mass effect from contusions, hematomas, or infarcts occupying more than 50-75% of the territory in stroke cases. In select instances, magnetic resonance imaging (MRI) may supplement CT to detect subtle ischemic changes or diffuse axonal injury not evident on initial scans, aiding in prognosis and contraindication identification such as extensive bilateral damage. For ICP monitor placement, CT also guides safe insertion sites, avoiding vascular structures or lesions. Invasive ICP monitoring is essential to document refractory hypertension before proceeding to surgery, as decompressive craniectomy is reserved for cases unresponsive to tiered medical management. The gold standard is an intraventricular catheter (external ventricular drain), which allows therapeutic cerebrospinal fluid drainage alongside pressure measurement, though intraparenchymal fiberoptic probes are alternatives when ventricular access is risky. Decompressive craniectomy is recommended for late refractory intracranial hypertension (>25 mmHg for 1-12 hours) despite maximal medical therapy (Level IIA evidence from RESCUEicp trial), but not for early refractory cases (>20 mmHg for >15 minutes; Level IIA from DECRA trial). The general treatment threshold is <22 mmHg. Continuous monitoring of cerebral perfusion pressure (typically targeted at 60-70 mmHg) accompanies assessment to guide preoperative optimization. Patient-specific factors must be addressed to minimize perioperative risks, involving input from neurosurgery, neurology, and intensive care teams. Coagulation status is evaluated and corrected if deranged; for instance, platelet counts should exceed 100,000/μL, and international normalized ratio (INR) below 1.4, with reversal of anticoagulants or antiplatelet agents where feasible, though recent evidence indicates no significant increase in hemorrhagic complications from preoperative antiplatelet use in TBI-related craniectomy. Sedation and ventilation are optimized to maintain stable hemodynamics and avoid exacerbating ICP, often using propofol or midazolam infusions titrated to minimize cerebral metabolic demand. Comorbidities such as hypertension or diabetes are managed aggressively, and baseline neurological status (e.g., Glasgow Coma Scale) is documented for outcome prognostication. Informed consent emphasizes the procedure's life-saving intent alongside substantial risks of disability, obtained from the patient if possible or surrogate decision-makers in impaired consciousness states. Discussions highlight potential outcomes, including a substantial risk of severe disability or vegetative state (approximately 40% of survivors in the at 6 months), with reduced mortality but higher rates of poor functional outcomes compared to medical management alone. Ethical considerations include proxy involvement and alignment with advance directives, given prognostic uncertainties in severe cases.

Operative technique

The operative technique for decompressive craniectomy is performed under general anesthesia with strict adherence to sterile protocols to minimize infection risk. The patient is positioned supine with the head turned 30-45 degrees to the contralateral side and secured using a Mayfield three-pin skull clamp for rigid fixation, ensuring optimal access to the surgical site while maintaining cerebral venous drainage. A curvilinear or question-mark incision is made along the temporoparietal region for unilateral procedures or across the bifrontal area, sparing the pinna and extending sufficiently to allow wide exposure. Multiple burr holes are created using a high-speed drill, connected with a craniotome to remove a large bone flap: in unilateral hemicraniectomy, a fronto-temporo-parietal flap measuring at least 12 cm in diameter (ideally 15 cm) is excised down to the floor of the middle cranial fossa; for bifrontal craniectomy, the flap spans from the orbital roof to the coronal suture bilaterally, crossing the midline while carefully avoiding injury to the superior sagittal sinus. The bone edges are inspected and smoothed to prevent compression of the underlying brain. The dura is then managed with a wide durotomy, typically in a stellate or cruciate fashion, to allow herniation of swollen brain tissue without constriction. To facilitate expansion and prevent re-closure, a duraplasty is performed using autologous materials such as pericranium or galea aponeurotica, or synthetic grafts like bovine pericardium, sutured loosely around the dural edges. Closure involves multilayer approximation of the scalp without tension, while the bone flap is removed and stored either in the patient's subcutaneous abdominal pocket or in a freezer at -20°C for future cranioplasty. If not already placed preoperatively, an intracranial pressure probe may be inserted through a separate burr hole. The procedure typically lasts 1-2 hours, emphasizing meticulous hemostasis and sterile technique throughout to optimize outcomes.

Clinical outcomes

Reduction of intracranial pressure

Decompressive craniectomy rapidly reduces elevated intracranial pressure (ICP) in patients with severe brain injury, typically lowering mean ICP from levels exceeding 40 mmHg to below 20 mmHg within hours of the procedure. In one study of patients with refractory ICP, the mean ICP decreased from 36.4 mmHg (range 18–80 mmHg) immediately post-craniectomy to 12.6 mmHg (range 2–51 mmHg), with this effect observed across cases where preoperative ICP was often above 40 mmHg. The magnitude of reduction correlates with the size of the bone flap removed, where defects larger than 80 cm²—such as those spanning 70–160 cm² in frontotemporoparietal craniectomies—facilitate greater decompression and more effective ICP control compared to smaller flaps. Clinical studies report success rates of 70–90% in achieving ICP below 20 mmHg, with one series noting this threshold met in 85% of monitored patients post-decompression. The primary mechanism involves increasing intracranial compliance by removing a portion of the rigid skull, which allows the brain to expand outward without proportional rises in pressure, thereby accommodating swelling from edema or hemorrhage. This enhances the brain's ability to tolerate volume increases while maintaining cerebral perfusion, as evidenced by improved pressure-volume index measurements post-procedure. Continuous monitoring via ICP waveform analysis is essential to assess this effect, as the procedure alters waveform components—including pulse, respiratory, and slow waves—indicating changes in cerebrovascular reactivity and compensatory reserve. Waveform evaluation helps confirm sustained compliance improvements and guides adjustments in management. The ICP reduction is generally sustained for weeks to months, persisting until cerebral edema resolves, after which pressure typically normalizes within 4 weeks in many cases. However, failure rates approximate 10%, often attributable to incomplete decompression from inadequate bone flap size or persistent mass lesions requiring reoperation. As an adjunctive measure, decompressive craniectomy is frequently combined with ventricular drainage via external ventricular drain placement to facilitate cerebrospinal fluid (CSF) removal, further lowering ICP by creating additional space within the ventricular system. This multimodal approach enhances overall pressure control in refractory cases. The effects on ICP reduction have been confirmed in major trials such as DECRA and RESCUEicp.

Functional outcomes

Decompressive craniectomy (DC) substantially lowers mortality rates compared to medical management alone in patients with severe traumatic brain injury (TBI) or malignant middle cerebral artery (MCA) infarction, with systematic reviews indicating a relative risk reduction of 41-50% across adult populations. Among survivors, however, 30-50% experience significant disability, often requiring long-term care or assistance with daily activities. Functional recovery is typically evaluated using the Glasgow Outcome Scale (GOS) or its extended version (GOSE), which categorize outcomes from death (GOS 1) to good recovery (GOS 5). Favorable outcomes (GOS 4-5, indicating moderate disability or better) occur in approximately 40-60% of adults under 40 years, though rates vary by underlying condition and patient characteristics. Key factors influencing functional outcomes include patient age, with younger individuals (<60 years) achieving higher rates of independence (up to 39% good functional outcome overall) compared to older patients, who face elevated risks of moderate-to-severe disability (over 50%). Surgical timing also plays a role; early (within 48 hours of symptom onset) correlates with better recovery in ischemic stroke cases, potentially due to preempting irreversible brain herniation, while in , outcomes improve with intervention before prolonged intracranial hypertension. Hemisphere involvement shows mixed results, with some evidence suggesting marginally better prospects for non-dominant hemisphere infarctions, though meta-analyses indicate comparable overall outcomes between dominant and non-dominant sides. Long-term, DC enhances survival rates but frequently results in increased dependency, with many survivors experiencing persistent neurological deficits that affect mobility, cognition, and self-care. A 24-month follow-up of the (ages 10-65 years) confirmed sustained mortality reduction (33.5% vs. 54.0% with medical care) but similar rates of good recovery (extended 7-8: 11.0% vs. 10.9%) and higher severe or moderate disability in the craniectomy group. The net impact on quality-adjusted life years () remains debated, as gains in lifespan are offset by reduced quality of life from disability; cost-utility analyses report variable QALY increments (0.14-0.35 per patient), highlighting the procedure's life-saving value alongside its disability burden.

Pediatric cases

Decompressive craniectomy in pediatric patients leverages the brain's greater neuroplasticity, resulting in higher rates of favorable outcomes compared to adults. Pooled data from 17 studies involving 186 children with traumatic brain injury who underwent hemicraniectomy showed a 6-month mortality rate of 21.1% and favorable outcomes (Glasgow Outcome Scale [GOS] scores 4-5) in approximately 78% of survivors (112 of 144). In contrast, the RESCUEicp trial (ages 10-65 years) reported favorable outcomes (extended GOSE 4-8) in 42.8% of the craniectomy group at 6 months. Children also experience lower complication rates, attributed to anatomical advantages such as thinner skull bones that facilitate surgical decompression with reduced blood loss and trauma, as well as more resilient dura that supports dural expansion. Recent analyses, however, suggest mixed results, with some evidence indicating DC may not reduce overall mortality or poor outcomes compared to medical management in pediatric TBI. Common indications for decompressive craniectomy in children include abusive head trauma, which accounts for up to 28% of cases requiring the procedure, and birth-related injuries such as subdural hemorrhages from perinatal trauma. Optimal timing is within 24-48 hours of injury to maximize cerebral protection, with early intervention (<24 hours) associated with improved functional recovery in pediatric series, though some studies show no significant difference between acute and subacute timing. Pediatric series and subgroup analyses, including a 2018 systematic review of 12 studies encompassing 260 patients, demonstrate reduced mortality with decompressive craniectomy compared to medical management alone (e.g., 0% vs. 34% in one series), without increasing rates of severe disability. The , which included patients as young as 10 years, supports these findings in older children, though dedicated pediatric subgroups were not separately analyzed. A major consideration in pediatric cases is the impact of skull defects on cranial growth, as the craniectomy site can lead to asymmetric development and bone resorption if left unrepaired. To mitigate these issues, earlier cranioplasty is recommended, typically 3-6 months post-craniectomy, to accommodate ongoing skull expansion and reduce resorption risks, with delays beyond 6 weeks increasing complication rates in children.

Evidence from clinical trials

DECRA trial

The DECRA (Decompressive Craniectomy in Patients with Severe Traumatic Brain Injury) trial was a multicenter, randomized controlled trial conducted from December 2002 to April 2010 across 15 tertiary care hospitals in Australia, New Zealand, and Saudi Arabia. It enrolled 155 adult patients aged 15 to 59 years with severe diffuse traumatic brain injury, defined by a Glasgow Coma Scale score of 3 to 8 and refractory intracranial hypertension (intracranial pressure >20 mm Hg for more than 15 minutes per hour despite first-tier medical therapies). Patients were randomized to either early bifrontotemporoparietal decompressive craniectomy (n=73) or continued standard medical management (n=82), with the surgical intervention performed within 72 hours of injury, typically as an early prophylactic measure rather than salvage therapy. The primary outcome was the Extended Glasgow Outcome Scale (GOSE) score at 6 months post-injury, with an unfavorable outcome defined as GOSE 1 to 4. Results showed that decompressive craniectomy effectively lowered mean (14.4 mm in the surgery group vs. 19.1 mm in the medical group; P<0.001) and reduced durations of mechanical ventilation, intensive care unit stay, and hospitalization. However, it was associated with worse functional outcomes, with 70% of the surgery group having unfavorable GOSE scores compared to 51% in the medical group (odds ratio for unfavorable outcome, 2.21; 95% CI, 1.14 to 4.26; P=0.02). Mortality rates were similar between groups at 6 months (19% vs. 18%). The trial faced several criticisms, including its relatively small sample size of 155 patients, which limited statistical power; exclusion of those with focal mass lesions, restricting generalizability to all traumatic brain injury cases; and early intervention timing (most surgeries within 40 hours of injury), which may not reflect typical salvage use for refractory hypertension. These limitations, along with baseline imbalances and lack of blinding, have been noted in subsequent analyses. Published in the New England Journal of Medicine in 2011, the DECRA trial influenced clinical guidelines, such as the 2020 Brain Trauma Foundation recommendations, which advise against early secondary decompressive craniectomy for refractory intracranial pressure elevation based on its findings of no mortality benefit and poorer functional outcomes, while favoring delayed approaches informed by later studies like RESCUEicp.

RESCUEicp trial

The RESCUEicp trial was an international, multicenter, parallel-group randomized controlled trial conducted from January 2004 to March 2014 across 52 centers in 20 countries, primarily led by the United Kingdom, enrolling 408 patients aged 10 to 65 years with traumatic brain injury (Glasgow Coma Scale score of 3–8) and refractory intracranial hypertension defined as intracranial pressure exceeding 25 mmHg for 1 to 12 hours despite first- and second-tier medical therapies per guidelines, along with an abnormal computed tomography scan. Patients were randomly assigned to receive either decompressive craniectomy (performed in 92.6% of cases) or continued medical management (with barbiturate coma induced in 87.2% of cases). The primary outcome was the Extended Glasgow Outcome Scale (GOSE) score at 6 months after injury, with secondary outcomes including mortality, GOSE at 12 and 24 months, and intracranial pressure control. At 6 months, decompressive craniectomy reduced mortality to 26.9% compared to 48.9% in the medical management group (P<0.001), representing a 22 percentage point absolute reduction, though it increased rates of vegetative state (8.5% vs. 2.1%) and severe disability (37.3% vs. 22.4%). Favorable outcomes (GOSE scores 4–8, encompassing upper severe disability or better) occurred in 42.8% of the surgical group versus 34.6% of the medical group (P=0.12), showing no significant overall difference but highlighting a survival benefit that shifted more patients from death to less favorable states. Decompressive craniectomy also achieved superior intracranial pressure control, with fewer patients requiring additional interventions. Subgroup analyses, including by age (≤40 years vs. >40 years), indicated greater benefit from in younger patients, where favorable outcomes reached 51.4% in the surgical group versus 36.2% in the medical group ( 15.2%, 95% 3.5–26.9%; interaction P=0.025). The trial results, published in 2016 in the New England Journal of Medicine, demonstrated that late decompressive craniectomy as salvage therapy after medical failure halves mortality in cases, though at the cost of increased severe among survivors. These findings influenced updated Brain Trauma Foundation guidelines, which in their 2020 revision provide level-IIA recommendations supporting large decompressive craniectomies (≥12 × 15 cm) for late refractory intracranial hypertension to improve mortality and select outcomes in adult and select pediatric patients. By emphasizing delayed intervention over early prophylactic use, addressed prior evidence gaps and shifted practice toward targeted salvage application in severe management.

Other studies

A pooled analysis of three randomized controlled trials—DECIMAL, DESTINY, and HAMLET—involving 93 patients aged 18–60 years with malignant middle cerebral artery infarction demonstrated that early decompressive craniectomy (within 48 hours of stroke onset) significantly reduced mortality to 22% compared to 71% in the control group, while achieving favorable functional outcomes (modified Rankin Scale [mRS] score ≤3) in 43% versus 21% of patients at one year. This analysis underscored the procedure's role in improving survival and moderate disability in younger stroke patients, though it highlighted the need for individualized decision-making due to potential severe impairments in survivors. Meta-analyses have synthesized across various etiologies, confirming a consistent mortality benefit from decompressive craniectomy. The 2019 Cochrane on high in , based on three randomized s with 420 participants, found moderate-quality of reduced death risk at six months (risk ratio 0.54, 95% CI 0.43–0.68), but low-quality indicated uncertain effects on neurological outcomes, with possible increases in severe . Similarly, the 2022 Cochrane review on surgical decompression for malignant cerebral oedema after ischaemic , drawing from s like DECIMAL, DESTINY, and , reported very low-certainty for reduced mortality but emphasized caution regarding and . The RESCUE-ASDH (2023), a multicenter randomized study of 440 adults with traumatic acute , compared decompressive craniectomy to and found similar extended Glasgow Outcome Scale scores at 12 months (common 0.85, 95% CI 0.60–1.21), indicating no clear superiority but comparable trends in mortality reduction alongside higher complication rates with craniectomy. Observational research has explored secondary decompressive craniectomy following initial hematoma evacuation. A 2025 retrospective cohort study of 101 patients who underwent primary decompressive craniectomy for severe found that secondary craniectomy was performed in 16 cases for refractory intracranial , with no significant differences in functional outcomes or complication rates compared to primary-only cases after adjustment, though predictors included higher preoperative and smaller initial craniectomy area. Despite these advances, significant research gaps persist, particularly in elderly patients over 65 years and non-Western populations. A 2024 multicenter study of 223 patients noted poorer functional outcomes and higher mortality in older adults undergoing decompressive craniectomy for , underscoring the limited high-quality data guiding its use in this demographic. Reviews have similarly highlighted underrepresentation of non-Western cohorts, with most evidence derived from and North trials, potentially limiting generalizability to diverse global settings.

Complications

Surgical risks

Decompressive craniectomy carries significant intraoperative risks, primarily related to hemorrhage, often originating from venous sinuses or cortical veins during and dura removal. exposure following dural opening can also lead to contusion expansion in up to 58% of patients, exacerbated by reperfusion and increased hydrostatic pressure gradients. These complications are mitigated through meticulous techniques, such as coagulation and hemostatic agents, alongside continuous () to guide the extent of . In the early postoperative period (within the first 30 days), infections represent a major concern, with wound infections affecting about 5-10% of patients and or occurring in 2-5% due to leaks or duraplasty breaches. develop in roughly 10-27% of cases, typically within 10 days, resulting from accumulation in the . Paradoxical herniation, a rare but life-threatening event seen in 1-3% of patients, arises from rapid reduction creating a negative pressure gradient, often if exceeds . Overall, major perioperative complications occur in 20-30% of decompressive craniectomy cases, encompassing hemorrhage, infection, and hygroma, though rates can reach higher in select series. Prophylactic antibiotics, such as cefazolin, reduce infection risk, while vigilant ICP monitoring and serial imaging aid early detection. Management typically involves reoperation for hematoma evacuation or expanding contusions, and targeted antibiotic therapy for infections, often guided by cerebrospinal fluid cultures.

Long-term issues

One of the primary long-term complications following decompressive craniectomy is the syndrome of the trephined, also known as sinking skin flap syndrome, which affects approximately 10% of patients with . This condition arises months to years after surgery when the scalp flap sinks inward, leading to altered cerebral blood flow and (CSF) dynamics due to atmospheric pressure on the exposed brain. Common manifestations include persistent headaches, cognitive decline such as memory impairment and executive dysfunction, and motor weakness, often contralateral to the craniectomy site. Symptoms typically resolve promptly after , highlighting the reversible nature of this syndrome when addressed through skull reconstruction. Hydrocephalus represents another significant chronic issue, occurring in about 16% of adult patients post-decompressive craniectomy. It develops due to perturbed CSF flow pathways disrupted by the surgical defect and brain shifts, with higher rates observed in cases of ischemic stroke (around 26%) and hemorrhagic stroke (21%). This complication usually emerges after the first month and can lead to progressive ventricular enlargement, necessitating interventions like ventriculoperitoneal shunting in 15-20% of affected individuals overall. Early recognition through and clinical is crucial, as untreated can exacerbate neurological deficits. Seizures are a frequent long-term concern, with an incidence ranging from 20% to 40%. The underlying mechanism involves a lowered from cortical irritation, scar tissue formation, and altered intracranial dynamics, often manifesting within the first year but persisting as in many cases. Prophylactic use of anticonvulsants remains controversial, as evidence on their efficacy in preventing late-onset seizures is mixed, though they are commonly initiated in high-risk patients. Additional long-term challenges include bone resorption when autologous bone flaps are used for eventual cranioplasty, affecting roughly 16% of adult cases and up to 39% in pediatric patients. This resorption, driven by factors such as delayed reconstruction and metabolic changes, can compromise structural integrity and necessitate revision surgery. Cosmetic deformities, such as scalp depression or contour irregularities, occur in about 3% of adults and are often linked to flap resorption or inadequate temporalis muscle preservation during initial surgery, impacting quality of life through visible asymmetry. These issues underscore the importance of timely cranioplasty to mitigate chronic morbidity.

Follow-up and recovery

Cranioplasty

is the performed to repair the defect resulting from decompressive craniectomy, restoring cranial integrity and protecting the once acute swelling has resolved. This procedure is essential to prevent long-term complications associated with persistent defects, such as the of the trephined. The timing of cranioplasty is typically 3 to 6 months after decompressive craniectomy to ensure resolution of , confirmed by computed tomography (CT) imaging. Recent 2025 meta-analyses indicate that early (within 3 months) may be associated with lower complication rates in adults, though optimal timing remains debated. In pediatric cases, earlier timing—often within 6 weeks—is recommended to support skull growth and minimize developmental disruptions. Autologous bone is the preferred material for cranioplasty due to its biocompatibility and low rejection risk; it is commonly stored frozen or in a subcutaneous abdominal pocket during the post-decompressive period. Synthetic alternatives include polymethylmethacrylate (), titanium mesh for customizable shaping, and 3D-printed implants designed via computer-aided modeling for precise fit. The surgical technique involves elevating the scalp flap, dissecting the dura if necessary, positioning the bone flap or over the defect, and securing it with plates and screws, akin to reversing the initial . Complication rates range from 10% to 30%, with infection representing the most frequent issue, often necessitating removal. Cranioplasty improves cerebral hemodynamics by enhancing blood flow, particularly ipsilaterally, and alleviating symptoms of the trephined syndrome, such as headaches and motor deficits. can lead to significant neurological improvements, including gains in cognitive and motor function, as demonstrated in a 2025 study.

Rehabilitation

Following decompressive craniectomy, the acute phase of rehabilitation begins in the (ICU) with close monitoring of neurological status, , and to prevent secondary brain injury. Patients are gradually weaned from as respiratory stability improves, often within the first few days to weeks, depending on the underlying condition such as or . To protect the exposed brain tissue from trauma during this period and prior to , custom-fitted helmets are routinely used, reducing the risk of injury during transfers and early movements. Rehabilitation involves a multidisciplinary team including physical therapists, occupational therapists, , and neuropsychologists to address motor deficits, (particularly in post-stroke cases), and cognitive impairments. Physical and occupational therapy focus on restoring strength, balance, and coordination through progressive exercises such as range-of-motion activities, gait training, and functional tasks to mitigate and . Speech therapy targets communication and swallowing difficulties, while neuropsychological interventions assess and rehabilitate , , and executive function to support overall independence. Intensive rehabilitation typically lasts 6-12 months, with inpatient phases emphasizing daily sessions of 1-2 hours and outpatient follow-up for sustained progress; goals center on achieving independence in (ADLs) such as and . Approximately 30-50% of patients attain moderate recovery, defined by favorable functional outcomes on scales like the Extended Outcome Scale, enabling community reintegration with assistance. Challenges in rehabilitation include managing persistent disabilities like and , which require ongoing family support for emotional and practical aid in daily routines. A 2025 study supports the use of passive head-up tilt positioning as a safe early mobilization strategy in to enhance neurological recovery and reduce complications in patients with impaired .

History

Early history

The origins of decompressive craniectomy can be traced to ancient trepanation, a surgical practice involving the or scraping of holes in the skull, dating back to the era around 7000 BCE. This procedure was performed across various cultures, with archaeological evidence from healed trephined skulls found in and , indicating it was used to treat head trauma or alleviate perceived ailments such as headaches, , or the release of "evil spirits." Approximately 5-10% of skulls examined show signs of trepanation, with survival rates evidenced by bone healing estimated at 70-90% in many samples, suggesting a surprisingly effective primitive technique despite the absence of modern or antisepsis. In the , decompressive craniectomy began to evolve as a more formalized neurosurgical intervention. Odilon Marc Lannelongue described linear craniectomy in 1890 as a method to address in infants by relieving through skull incisions, marking an early systematic approach to cranial . Shortly thereafter, Thomas Annandale reported in 1894 on decompressive craniectomy as a palliative measure for inoperable tumors, expanding its application beyond congenital conditions to pathological states involving elevated . Early 20th-century advancements were pioneered by Harvey Cushing, who in 1905 advocated subtemporal decompressive craniectomy for inaccessible brain tumors, performing subtotal skull resections to accommodate swelling and reduce mortality. This approach significantly lowered operative death rates in , with Cushing's overall tumor surgery mortality dropping from around 50-90% in prior eras to under 13% by 1910 through refined techniques and . However, in the pre-antibiotic era before the , high postoperative rates—approaching 100% mortality in some intracranial cases—severely limited the procedure's widespread adoption due to risks of and .

Modern developments

Decompressive craniectomy gained prominence in during , refined by Harvey Cushing for severe head injuries in soldiers, and continued in and conflicts like the , where rapid skull decompression was employed to mitigate and facilitate of fragments. This approach became a standard in forward surgical settings during conflicts like the , emphasizing early intervention to improve survival rates in combat casualties. In the 1970s, advancements in microsurgical techniques and monitoring, pioneered by Nils Lundberg, revolutionized the timing and precision of decompressive craniectomy. Lundberg's development of continuous measurement via ventricular catheters allowed clinicians to detect refractory hypertension earlier, guiding surgical decisions and reducing risks associated with delayed intervention in severe TBI cases. During the and , randomized controlled trials (RCTs) began establishing a stronger evidence base for decompressive craniectomy, particularly in non-TBI contexts like . Key RCTs, such as DESTINY (2007) and (2007), demonstrated reduced mortality in patients with malignant through hemicraniectomy, influencing broader adoption. Concurrently, the Eurotherm3235 trial (initiated in the and published in 2015) evaluated therapeutic (32–35°C) as an adjunct to control, including in conjunction with craniectomy, though it highlighted risks of poorer functional outcomes without clear mortality benefits. The 2016 publication of the RESCUEicp trial marked a pivotal shift, positioning decompressive craniectomy as a salvage for intracranial hypertension in TBI patients unresponsive to medical management. This international RCT showed that late craniectomy reduced mortality from 49% to 27% at 6 months compared to continued medical , albeit with increased rates of severe , prompting its recommendation as a tier-3 in guidelines. In the 2020s, research has emphasized minimally invasive variants, such as limited craniectomy, to balance relief with reduced tissue disruption and complications. These approaches involve smaller flaps or endoscopic assistance, showing promise in select TBI cases for shorter recovery times. Parallel innovations in biomaterials for subsequent have improved outcomes, with regenerative options like composites and antimicrobial-modified implants reducing infection rates and promoting integration. As of 2025, AI-assisted imaging tools have enhanced patient selection for decompressive craniectomy by predicting outcomes from scans and narratives, aiding in the identification of candidates likely to benefit and thereby optimizing resource use. Global guidelines, including those from the American Association of Neurological Surgeons (AANS) and Brain Trauma Foundation, have been refined for pediatric applications, weakly recommending craniectomy in cases of neurologic deterioration or refractory while stressing individualized assessment.

References

  1. [1]
    Decompressive craniectomy: A primer for acute care practitioners
    Mar 24, 2024 · Decompressive craniectomy (DC) involves surgical removal of the skull that overlies swollen, imperiled, brain.
  2. [2]
    Trial of Decompressive Craniectomy for Traumatic Intracranial ...
    Sep 7, 2016 · At 6 months, decompressive craniectomy in patients with traumatic brain injury and refractory intracranial hypertension resulted in lower mortality.
  3. [3]
    The History of Decompressive Craniectomy in Traumatic Brain Injury
    Decompressive craniectomy consists of removal of piece of bone of the skull in order to reduce intracranial pressure. It is an age-old procedure.
  4. [4]
    Decompressive Craniectomy in Severe Traumatic Brain Injury - MDPI
    Jan 30, 2023 · As a general rule, unilateral DC should not be smaller than 12 × 15 or 15 cm in diameter and extended toward the floor of the temporal fossa to ...3. Discussion · 3.1. Traumatic Brain Injury... · 3.4. Decompressive...Missing: distinction | Show results with:distinction<|control11|><|separator|>
  5. [5]
    Decompressive craniectomy for traumatic brain injury: a review of ...
    Apr 14, 2025 · A large bone flap measuring at minimum 12–15 cm should be created.3 4 An additional option may be a 'hinge' craniectomy, where the bone flap is ...Missing: distinction | Show results with:distinction
  6. [6]
    Decompressive Craniectomy - PubMed
    Decompressive Craniectomy (DC) is used to treat elevated intracranial pressure that is unresponsive to conventional treatment modalities.
  7. [7]
    Decompressive Craniectomy in Traumatic Brain Injury - NIH
    Bifrontal craniectomy allows for frontal contusion of the brain and useful in the cases of generalized cerebral edema without localized lesion.
  8. [8]
    Decompressive craniectomy of post-traumatic brain injury - Nature
    Oct 29, 2020 · The most common locations of craniectomy are unilateral with an opening on the left or right hemisphere and bilateral with a bifrontal opening ...
  9. [9]
    Craniotomy vs. craniectomy: What's the difference?
    Nov 18, 2024 · Again, 'crani-' refers to the skull, but '-ectomy' means 'to cut out.' So, craniectomy means to cut out the bone. Much like a craniotomy, when ...
  10. [10]
    Craniotomy vs. Craniectomy vs. Cranioplasty
    Mar 19, 2019 · The key difference between craniotomy and craniectomy is whether the skull bone is replaced after the procedure.
  11. [11]
    Trephinations to Craniotomies: Early Innovations in Neurosurgery
    Learn more about the surprising success rates of ancient trephinations and what prompted the first craniotomy.Missing: decompressive craniectomy
  12. [12]
    Cerebral Perfusion Pressure - StatPearls - NCBI Bookshelf
    It is the difference between the mean arterial pressure (MAP) and the intracranial pressure (ICP), measured in millimeters of mercury (mm Hg).
  13. [13]
    Effect of decompressive craniectomy on intracranial pressure and ...
    In this study, decompressive craniectomy led to a sustained reduction in ICP and improvement in cerebral compliance. Lower MAP levels after decompressive ...Missing: dV/ dP
  14. [14]
    Management of Intracranial Pressure - Continuum (AAN)
    Compliance can be conceptualized as how stretchy an object is (ie, volume change) due to changes in pressure (ie, C = dV/dP, where dV equals change in volume ...
  15. [15]
    Decompressive craniectomy in a rat model of "malignant" cerebral ...
    Neurological behavior and infarction size were significantly better in animals treated very early by decompressive craniectomy (4 hours) after endovascular MCA ...
  16. [16]
    Guidelines for the Management of Severe Traumatic Brain Injury
    The temporary removal of a large portion of skull–termed decompressive craniectomy (DC)–has long been part of the neurosurgeon's armamentarium for treating ICP ...
  17. [17]
    Closed Head Injury Treatment & Management - Medscape Reference
    May 4, 2022 · Medical management of increased ICP should include sedation and paralysis, drainage of CSF, and osmotherapy with either mannitol or hypertonic ...Medical Care · Normal Values Of... · Treatment Considerations
  18. [18]
    Decompressive craniectomy for traumatic intracranial hypertension
    Sep 6, 2017 · A retrospective study on 23 patients who underwent decompression for diffuse axonal injury or contusions reported survival in 16 patients, 13 ...
  19. [19]
    Decompressive craniectomy for traumatic brain injury: patient age ...
    Many authors state there is no significant benefit in performing a DC in severe head injury after a certain age limit, with most placing the limit at 30-50 ...
  20. [20]
    Recommendations for the Management of Cerebral and Cerebellar ...
    Jan 30, 2014 · In swollen cerebellar stroke, suboccipital craniectomy with dural expansion should be performed in patients who deteriorate neurologically.
  21. [21]
    Decompressive Hemicraniectomy for Large Hemispheric Strokes
    Mar 15, 2021 · Large hemispheric infarcts occur in up to 10% of all ischemic strokes and can cause devastating disability.
  22. [22]
    Decompressive craniectomy for acute ischemic stroke - Critical Care
    Jun 7, 2019 · Decompressive craniectomy (DC) is a surgical technique aiming to open the “closed box” represented by the non-expandable skull in cases of refractory ...Background · Technical Aspects Of Dc · Supratentorial Malignant...
  23. [23]
    Hemicraniectomy for Dominant vs Nondominant Middle Cerebral ...
    This meta-analysis suggests that patients with dominant-hemispheric stroke have equal outcome after hemicraniectomy compared to patients with nondominant stroke
  24. [24]
    Severe cerebral edema following nivolumab treatment for pediatric ...
    Nov 18, 2016 · Computed tomography of her brain revealed malignant cerebral edema requiring emergency decompressive hemicraniectomy. ... glioblastoma ...
  25. [25]
    Bacterial Brain Abscess and Life-Threatening Intracranial ...
    Mar 16, 2023 · Abscess sizes greater than 2.5 cm in diameter with extensions into surrounding brain structures can result in brain edema and herniation ...
  26. [26]
    [PDF] A fatal case report of Plasmodium falciparum malaria complicated by ...
    9 After confir- mation of a subdural hematoma, the patient underwent intracranial hematoma evacua- tion and decompressive craniectomy. However, the ...
  27. [27]
    Decompressive bifrontal craniectomy for malignant intracranial ...
    These include primary and diffuse hypoxic brain injury, intracranial hematomas, cerebral ischemia or infarction, and obstructive hydrocephalus.Missing: encephalopathy | Show results with:encephalopathy
  28. [28]
    Elevated intracranial pressure requiring decompressive craniectomy ...
    Aug 6, 2021 · Decompressive craniectomy might be considered in cases of ... status epilepticus. She had elevated inflammatory markers with ...
  29. [29]
    Cranial decompression and expansion surgery for the treatment of ...
    Dec 30, 2021 · Cranial vault decompression or expansion surgeries may be an effective last resort therapy for patients with refractory IIH.
  30. [30]
    Comparison of outcomes following decompressive craniectomy in ...
    The mortality rate in patients with abusive brain injury (35.7%) was significantly higher (p < 0.05) than in patients with other causes of traumatic brain ...
  31. [31]
    Surgical Decompression for Malignant Cerebral Edema After ...
    Nov 27, 2023 · Decompressive hemicraniectomy results in a substantial reduction of death, death, or severe disability (mRS score >4), and a reduction of death or moderate ...
  32. [32]
    [PDF] Decompressive craniectomy :
    Decompressive craniectomy(DC) has been used as a final option in the ... CONTRAINDICATION fatal brain stem damage : GCS < 4 or fixed and dilated ...
  33. [33]
    Guidelines for the Management of Severe Traumatic Brain Injury
    Aug 6, 2020 · The update to the decompressive craniectomy chapter presented here integrates the findings of the RESCUEicp study as well as the recently published 12-mo ...
  34. [34]
    Intracranial Pressure Monitoring - StatPearls - NCBI Bookshelf - NIH
    Jan 23, 2024 · The patient should be strictly monitored for any signs of clinical deterioration for at least 24 hours, with all preparations made for emergency ...
  35. [35]
    Invasive Monitoring of Intracranial Pressure After Decompressive ...
    Dec 4, 2020 · In this study, we investigated the role of invasive ICP monitoring in patients after DC for MCI, postulating that postoperative ICP predicts mortality.
  36. [36]
    The effect of antiplatelet and anticoagulant therapies on clinical ...
    Feb 6, 2024 · The effect of antiplatelet and anticoagulant therapies on clinical outcome of patients undergoing decompressive craniectomy: a systematic review.
  37. [37]
    Preoperative Assessment of Adult Patients for Intracranial Surgery
    This article provides an overview of the preoperative evaluation of these patients with respect to general principles of neuroanesthesia.
  38. [38]
    a study of Australian anaesthetists - PubMed
    The aim of this study was to assess the influence of detailed prognostic information on the likelihood of informed consent for decompressive craniectomy for ...<|control11|><|separator|>
  39. [39]
    Decompressive craniectomy in trauma: What you need to know - PMC
    Aug 9, 2024 · The bone flap size should be large, and the dura should be widely opened. ... Decompressive craniotomy allows the bone flap to “hinge” or “float ...
  40. [40]
    Craniotomy, Craniectomy | Mayfield Brain & Spine, Cincinati, OH
    The patient's head is placed in a three-pin Mayfield skull clamp which holds the head absolutely still during delicate brain surgery. The hair is shaved ...
  41. [41]
    Decompressive craniectomy-operative technique and perioperative ...
    Aug 5, 2025 · This article focuses on the current indications and rationale for decompressive craniectomy, and the surgical technique of bifrontal and ...
  42. [42]
    Decompressive Craniectomy and Traumatic Brain Injury: A Review
    Regard dural opening can be used different ways of opening that includes fish-mouth incision, stellate incision, C-shaped fashion incision and cruciate incision ...
  43. [43]
    A review on decompressive craniectomy for traumatic brain injury
    Dec 1, 2023 · There could be autologous tissues, such as pericranium or fascia lata, or artificial dural substitutes mainly derived from bovine tendon among ...
  44. [44]
    Bovine pericardium for duraplasty: Clinical results in 32 patients
    Aug 6, 2025 · Bovine pericardium has been widely used for grafts in cardiac surgery and seems to have suitable properties for use as a dural graft.
  45. [45]
    Technical Considerations in Decompressive Craniectomy in the ...
    Nov 8, 2010 · By removing part of the skull, decompressive craniectomy seeks to prevent herniation and to reconstruct cerebral blood perfusion to improve ...
  46. [46]
    Effective ICP reduction by decompressive craniectomy in patients ...
    We found a significant reduction of the ICP directly after craniectomy, from 36.4 mm Hg (range, 18-80 mm Hg) to 12.6 mm Hg (range, 2-51 mm Hg). During the ...Missing: bone flap size cm²
  47. [47]
    Hinge craniotomy as an alternative technique for patients with ...
    They found that for an area of 70–160 cm2, flap size was an independent factor in reducing ICP, but not for overall neurological outcome (Reid et al., 2018).
  48. [48]
    Outcome following decompressive craniectomy for malignant ...
    Decompressive craniectomy lowered ICP to less than 20 mm Hg in 85% of patients. In the 40 patients who had undergone ICP monitoring before decompression, ICP ...Missing: success | Show results with:success
  49. [49]
    Effect of decompressive craniectomy on intracranial pressure and ...
    A significantly lower mean arterial pressure (MAP) was needed after decompressive craniectomy to maintain optimum cerebral perfusion pressure (CPP) levels, ...
  50. [50]
    Prediction of early mortality after primary decompressive ...
    Apr 15, 2021 · On the other hand, the ICP returns to normal level within 4 weeks after trauma [13], and according to this finding, decompressive craniectomy ...
  51. [51]
    Complications of Decompressive Craniectomy - Frontiers
    Nov 19, 2018 · Early complications · Hemorrhage · External Cerebral Herniation · Wound Complications · CSF Leak/Fistulae · Postoperative Infections · Seizures/ ...Missing: contraindications | Show results with:contraindications
  52. [52]
    Technique of Stepwise Intracranial Decompression Combined with ...
    Sep 14, 2015 · Decompressive craniectomy (DC) is the primary method used to treat ICP. DC can prevent the increase in cranial volume and reduce ICP, thereby ...
  53. [53]
    Decompressive craniectomy in the management of intracranial ...
    Aug 18, 2017 · Early decompressive craniectomy may be effective in the treatment of refractory intracranial hypertension after traumatic brain injury.
  54. [54]
    A Systematic Review and Meta-Analysis - PubMed
    Conclusions: DHC could significantly improve GFO and reduces mortality of patients of all ages with malignant MCA infarction compared with CT, without ...
  55. [55]
    Functional Outcome of Adult Traumatic Brain Injury Patients Treated ...
    Primary DC was performed in 93.2% of cases. The in-hospital and overall mortality rates were 24.3% and 36.5% respectively. Overall, a favorable functional ...
  56. [56]
    Assessment of outcome following decompressive craniectomy for ...
    The importance of preoperative neurological status, hemispheric dominance, timing of surgery after onset of stroke, and patient age are a few factors that may ...
  57. [57]
    Hemicraniectomy for Dominant vs Nondominant Middle Cerebral ...
    This meta-analysis suggests that patients with dominant-hemispheric stroke have equal outcome after hemicraniectomy compared to patients with nondominant stroke ...
  58. [58]
    Cost-Effectiveness of Surgical Decompression for Space-Occupying ...
    After 3 years, 5 surgical (24%) and 14 medical patients (78%) had died. In the first 3 years after enrollment, operated patients had more QALYs than medically ...Abstract · Methods · Results
  59. [59]
    An economic evaluation for the use of decompressive craniectomy ...
    Mar 21, 2021 · A cost-utility analysis was then carried out over a 1-year time horizon, measuring benefits in quality adjusted life years (QALYs) and costs in ...
  60. [60]
    Decompressive Craniectomy in Diffuse Traumatic Brain Injury
    Mar 25, 2011 · In such cases, surgical decompressive craniectomy is performed with increasing frequency to control intracranial pressure. We designed the ...
  61. [61]
    Decompressive craniectomy for traumatic brain injury: a review ... - NIH
    Apr 14, 2025 · This article reviews the recent studies evaluating the role of DC in the management of elevated intracranial pressures (ICPs) associated with TBI and its ...
  62. [62]
    Evaluation of Outcomes Among Patients With Traumatic Intracranial ...
    Jun 6, 2022 · Decompressive craniectomy is a life-saving procedure to reduce critically elevated intracranial pressure (ICP) among patients with traumatic ...<|control11|><|separator|>
  63. [63]
    None
    ### Summary of Subgroup Analyses for Age in RESCUEicp Trial (Supplementary Appendix)
  64. [64]
    Updated Review of the Management of and Guidelines for ... - MDPI
    The Brain Trauma Foundation's fourth-edition guidelines, updated in 2020 following the Trial of Decompressive Craniectomy for Traumatic Intracranial ...
  65. [65]
    Early decompressive surgery in malignant infarction of the middle ...
    In patients with malignant MCA infarction, decompressive surgery undertaken within 48 h of stroke onset reduces mortality and increases the number of patients ...
  66. [66]
    Decompressive craniectomy for the treatment of high intracranial ...
    Dec 31, 2019 · This Cochrane Review investigated the effects of a surgical procedure, decompressive craniectomy (DC), on survival and neurological (functional) ...
  67. [67]
    Surgical decompression for malignant cerebral oedema after ...
    Nov 16, 2022 · Early decompressive craniectomy to relieve intracranial pressure and associated tissue shift can help ameliorate this secondary damage and ...
  68. [68]
    Decompressive Craniectomy versus Craniotomy for Acute Subdural ...
    However, the most common indication for a decompressive craniectomy is a traumatic subdural hematoma. Because acute subdural hematomas are often associated with ...Craniectomy Vs. Craniotomy... · Trial Design And Oversight · Statistical Analysis
  69. [69]
    Secondary decompressive craniectomy after severe traumatic brain ...
    Sep 16, 2025 · Secondary DC may serve as an effective salvage intervention in sTBI patients with refractory intracranial hypertension following primary DC.
  70. [70]
    Outcome after decompressive craniectomy in older adults ... - PubMed
    Jul 8, 2024 · The aim of this study was to investigate the outcome after TBI and decompressive craniectomy (DC) in older adults compared with younger patients.
  71. [71]
  72. [72]
  73. [73]
    Paradoxical Herniation After Unilateral Decompressive Craniectomy ...
    In the current study, the rate of paradoxical herniation after DC is 3.0%. However, we observed sinking skin flap only in the 8 cases of paradoxical herniation ...
  74. [74]
    Complications Associated with Decompressive Craniectomy - NIH
    Overall, the adult population had similar rates of superficial complications compared to the pediatric population, at 9.6 % (163/1698) and 10.1 % (11/109), ...
  75. [75]
    Cranioplasty: A Multidisciplinary Approach - Frontiers
    May 16, 2022 · Four time frames (post craniectomy) were agreed upon (86.8% agreement): ultra early—up to 6 weeks; early cranioplasty—6 weeks to 3 months; ...Introduction · Clinical Indications · Timing · Outcomes Following...
  76. [76]
    The effect of cranioplasty on cerebral hemodynamics:...
    Fourteen of the patients with “syndrome of the trephined” reported that they had improved after cranioplasty. Their main complaints of headache, insomnia ...Missing: benefits | Show results with:benefits
  77. [77]
    Optimal Timing of Cranioplasty After Decompressive Craniectomy
    Although early intervention, typically around 3 months post-DC, is often recommended to ensure adequate neurological recovery and minimize brain tissue swelling ...
  78. [78]
    Optimal timing of autologous cranioplasty after decompressive ...
    Conclusions: After decompressive craniectomy for raised intracranial pressure in children, early (< 6 weeks) cranioplasty reduces the occurrence of reoperation ...
  79. [79]
    Different materials of cranioplasty for patients undergoing ... - NIH
    Nov 24, 2021 · 2.1.3. Types of interventions · 1. autologous bone, · 2. allografts, · 3. titanium mesh, · 4. hydroxyapatite, · 5. methylmethacrylate, · 6. alumina ...
  80. [80]
    Cranioplasty: Review of materials and techniques - PMC - NIH
    The main considerations of these techniques are to use patients' own bone tissue to achieve bony closure and to keep bone flap “alive” in waiting period.
  81. [81]
    Neurocognitive outcome post cranioplasty: The role of cerebral ... - NIH
    Jun 21, 2024 · Cranioplasty leads to a marked improvement in cerebral hemodynamics, which is more significant on the ipsilateral side. It also leads to increased CSF turnover ...
  82. [82]
    Impact of cranioplasty on cerebral blood flow perfusion and ...
    May 2, 2025 · The results of this study suggest that decompressive craniectomy has different effects on cerebral blood flow perfusion in patients with ...
  83. [83]
    ICU care post craniotomy - EMCrit Project
    Jun 23, 2022 · This is especially likely if surgery occurs nearby (e.g., posterior fossa surgery may cause edema or clots which obstruct the fourth ventricle).Missing: arrest | Show results with:arrest<|separator|>
  84. [84]
    Reviving Consciousness: A Neurophysiotherapy Triumph in ... - NIH
    Jan 14, 2024 · The rehabilitation protocol involved diverse strategies such as passive and active exercises, sensory stimulation, and the application of ...
  85. [85]
    Decompressive Craniectomy (DC) - Physiopedia
    Decompressive craniectomy is a neurosurgical procedure used to treat life-threatening elevations in intracranial pressure caused by cerebral edema.Decompressive Craniectomy... · Types of surgical decompression
  86. [86]
    Cranioplasty: A Multidisciplinary Approach - PMC - NIH
    May 17, 2022 · Patients following decompressive craniectomy often require complex disability management as described above, and structured periods of inpatient ...
  87. [87]
    The Role of Decompressive Craniectomy on Functional Outcome ...
    Mar 29, 2023 · Decompressive craniectomy (DC) represents a useful neurosurgical procedure to counteract the TBI-related increase of ICP and to improve the ...
  88. [88]
    Evaluation of Outcomes Among Patients With Traumatic Intracranial ...
    Jun 6, 2022 · The initial RESCUEicp trial results suggested that the reduced mortality rate as a result of decompressive craniectomy translates to both ...
  89. [89]
    Passive head-up tilt positioning as an early mobilization strategy in ...
    Aug 8, 2025 · Early mobilization is recommended in neurocritical care, yet passive mobilization strategies for patients with impaired consciousness remain ...
  90. [90]
    Neolithic trepanation decoded- A unifying hypothesis: Has the ...
    May 7, 2015 · Most reported series show that from 5-10% of all skulls found from the Neolithic period have been trephined with single or multiple skull ...
  91. [91]
    LINEAR CRANIOTOMY (MISCALLED CRANIECTOMY) FOR ...
    Dec 18, 2018 · Published August 8, 1891 | Version v1. Journal article Open. LINEAR CRANIOTOMY (MISCALLED CRANIECTOMY) FOR MICROCEPHALUS.Read in the Section ...
  92. [92]
    The History of Decompressive Craniectomy in Traumatic Brain Injury
    May 8, 2019 · Decompressive craniectomy consists of removal of piece of bone of the skull in order to reduce intracranial pressure. It is an age-old procedure.
  93. [93]
    modern neurosurgery's definitive development in Harvey Cushing's ...
    By 1910 Cushing had operated on 180 tumors; he had a thriving practice, with a patient mortality rate of less than 13%.Missing: subtotal resection
  94. [94]
    [PDF] 78 Cranial Epidural Abscess and Subdural Empyema
    Until penicillin be- came widely available in the 1940s, mortality from these in- fections approached 100%. Contemporary reports now cite mortality rates for ...<|control11|><|separator|>
  95. [95]
    Surgical Management of Penetrating Brain Injury - Lippincott
    Indeed, in the United States military, thorough debridement of intracranial bone and metal fragments was official military policy through the Vietnam War. Such ...<|separator|>
  96. [96]
    Military Traumatic Brain Injury: The History, Impact, and Future
    Those with penetrating head wounds typically had three-dimensional skull films taken, and then a craniotomy within 90 min of injury. A water-tight dural closure ...
  97. [97]
    Monitoring and interpretation of intracranial pressure - PMC
    ICP monitoring is useful, if not essential, in head injury, poor grade subarachnoid haemorrhage, stroke, intracerebral haematoma, meningitis, acute liver ...
  98. [98]
    Measuring intracranial pressure by invasive, less invasive or non ...
    May 6, 2020 · Sixty years have passed since neurosurgeon Nils Lundberg presented his thesis about intracranial pressure (ICP) monitoring, which represents ...Missing: microsurgery decompressive craniectomy
  99. [99]
    Therapeutic hypothermia to reduce intracranial pressure after ... - NCBI
    The Eurotherm3235 Trial was a pragmatic trial examining the effectiveness of hypothermia (32–35 °C) to reduce raised intracranial pressure (ICP) following ...Missing: 1990s- 2000s
  100. [100]
    Trial of Decompressive Craniectomy for Traumatic Intracranial ...
    Sep 22, 2016 · Methods: From 2004 through 2014, we randomly assigned 408 patients, 10 to 65 years of age, with traumatic brain injury and refractory elevated ...Missing: pediatric subgroup
  101. [101]
    Evolution from Decompressive Craniectomy to Early Minimally ...
    The Monro-Kellie doctrine explains the dynamics of the three main components within the cranial vault: brain tissue, cerebral blood flow, and cerebrospinal ...
  102. [102]
    Biomaterials for Regenerative Cranioplasty: Current State of Clinical ...
    This review examines the current state of research, development, and translational application of regenerative cranioplasty biomaterials
  103. [103]
    Antimicrobial Biomaterials for Cranioplasty: A Systematic Review
    May 13, 2025 · Antimicrobial modifications to cranioplasty materials show promising preclinical results, with favorable local release profiles and minimal systemic ...
  104. [104]
    AI for Mortality Prediction from Head Trauma Narratives | medRxiv
    Feb 21, 2025 · AI-driven mortality prediction from text can assist in identifying critically injured patients who require immediate neurosurgical evaluation, ...
  105. [105]
    Decompressive Craniectomy Following Traumatic Brain Injury in ...
    Oct 22, 2025 · ... meta-analysis of DC for TBI in pediatric patients. No significant differences in outcomes were observed between pediatric patients with ...